STOCKHOLDERS’ DEFICIENCY (Details Narrative) - USD ($)				3 Months Ended					6 Months Ended		12 Months Ended
STOCKHOLDERS’ DEFICIENCY (Details Narrative) - USD ($)	Sep. 19, 2023	Sep. 19, 2023	Dec. 21, 2021	Sep. 30, 2025	Jun. 30, 2025	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2025	Sep. 30, 2024	Mar. 31, 2025	Mar. 31, 2023	Nov. 30, 2024	Jun. 30, 2024	Feb. 02, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares authorized				125,000,000					125,000,000		125,000,000
Common stock, par value				$ 0.001					$ 0.001		$ 0.001
Preferred stock, shares authorized				9,979,400					9,979,400		9,979,400
Preferred stock convertible conversion price				$ 0.001					$ 0.001		$ 0.001
Common stock, shares issued				26,791,608					26,791,608		26,081,295
Common stock, other shares, outstanding				160,672					160,672		160,672
Preferred stock, shares issued				1					1		1
Preferred stock, shares outstanding				1					1		1
Debt instrument redemption price percentage									110.00%
Proceeds from issuance of preferred stock and preference stock										$ 1,732,532
Net proceeds from new issue value
Debt conversion description												The redemption price was determined in accordance with the Series B note agreement, where the Company has an option to redeem the note at 115% of its principal value instead of converting the note upon receipt of a conversion notice. The difference between the redemption cash payment and the book value of the note
Conversion of common shares									(50,000)	$ (285,814)
Accrued dividends liability								$ 16,789
Number of stock issued during the period convertible, shares										97,811
Temporary Equity, Accretion to Redemption Value, Adjustment											$ 571,629
Increase or decrease in temporary equity				$ 143,351
Face value			$ 12,400,000										$ 1,500,000
Loss on debt conversion										$ 249,093
Gross proceeds from issuance of common stock										125,227
Issuance of warrants			$ 198,713
Shares to be issued with fair value						$ 20,000				81,120
Share based compensation									$ 11,936	$ 115,863
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of options outstanding				3,067,830					3,067,830
Weighted average exercise price				$ 1.14					$ 1.14
2016 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award number of shares authorized															1,241,422
Shares granted						250,000				291,559
Share based compensation				$ 6,001		$ 56,885			$ 11,936	$ 115,863
2023 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate shares												5,000,000
General and Administrative Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of shares for services										70,000
Issuance of warrants										$ 53,480
Series C Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt conversion description											Notes would convert into common stock at the applicable “Mandatory Conversion Price”, if either (i) on each of any twenty (20) consecutive trading days (the “Measurement Period”) (A) the closing price of the common stock on the applicable trading market is at least $18.00 per share and (B) the dollar value of average daily trades of the common stock on the applicable trading market is at least $400,000 per trading day; or (ii) upon the closing of a Qualified Financing, provided that the dollar value of average daily trades of the common stock on the applicable exchange on each of the ten (10) consecutive trading days following such closing is at least $400,000 per trading day. Mandatory Conversion Price means, in the case of a Mandatory Conversion under situation (i) above, seventy percent (70%) of the VWAP over the Measurement Period, or in the case of a Mandatory Conversion under situation (ii) above, eighty percent (80%) of the gross sale price per share of common stock (or conversion or exercise price per share of common stock of any common stock equivalents) sold in a Qualified Financing
Instrument amount						45,000				1,432,700
Fair value of common shares						74,618				2,283,216
Debt instrument accrued interest						7,810				222,257
Derivative liability						15,357				490,972
Debt instrument accrued interest						$ 6,451				$ 137,287
Converted instrument shares issued						121,043				1,753,554
Series C Convertible Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares from shares to be issued										287,802
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted average exercise price				$ 1.360		$ 0.733			$ 1.360	$ 0.733
Purchase Agreement [Member] \| Beneficiary [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Ownership percentage	4.99%	4.99%
Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares issued				26,791,608					26,791,608		26,081,295
Shareholders [Member] \| Exchange Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares outstanding				26,767,370					26,767,370		26,241,967
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized				20,000					20,000		20,000
Preferred stock convertible conversion price				$ 0.001					$ 0.001		$ 0.001
Preferred stock, shares issued				201		201			201	201	201
Preferred stock, shares outstanding				201		201			201	201	201
Preferred stock, liquidation preference				$ 100					$ 100
Preferred stock dividend rate percentage									12.00%
Debt instrument redemption price percentage									5.00%
Preferred stock convertible conversion price				$ 0.001					$ 0.001
Volume weighted average price percentage									15.00%
Initial conversion price	$ 3.50	$ 3.50
Face value						$ 6,104,444				$ 6,104,444
Accrued dividends						1,071,542				$ 1,071,542
Converted instrument shares issued										8,952,170
Deposit liabilities, accrued interest						$ 7,984,463				$ 7,984,463
Stock redeemed or called during period, value										11,039,142
Investment company, dividend distribution										$ 3,054,679
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized				600					600		600
Preferred stock convertible conversion price				$ 0.001					$ 0.001		$ 0.001
Preferred stock, shares issued	220	220		360					360		385
Preferred stock, shares outstanding				360					360		385
Preferred stock redemption price per share	$ 9,091	$ 9,091
Proceeds from issuance of preferred stock and preference stock	$ 1,900,000
Stock issued					486,474
Debt conversion description		Holders may elect to convert shares of Series B Preferred Stock to common stock at an alternate conversion price equal to 80% (or 70% if the Company’s common stock is suspended from trading on or delisted from a principal trading market or if the Company has effected a reverse split of the common stock) of the lowest daily volume weighed average price of the common stock during the Alternate Conversion Measuring Period (as defined in the Series B Certificate of Designations). In the event the Company receives a conversion notice that elects an alternate conversion price, the Company may, at its option, elect to satisfy its obligation under such conversion with payment in cash in an amount equal to 110% of the conversion amount
Conversion of mezzanine equity into common shares						1,091,063		40		1,436,267
Conversion of preferred stock shares				25		25	25			50	100
Issuance of common shares from shares to be issued				223,839	486,474					320,321
Series B Preferred Stock [Member] \| Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock convertible conversion price	$ 10,000	$ 10,000
Preferred stock, shares issued	600	600
Debt instrument redemption price percentage		110.00%
[custom:StatedValuePercentage-0]	8.00%	8.00%
Series B Preferred Stock [Member] \| Purchase Agreement [Member] \| Beneficiary [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Ownership percentage	19.90%	19.90%
Series B Preferred Stock [Member] \| Purchase Agreement [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
[custom:StatedValuePercentage-0]	15.00%	15.00%
Series C Convertible Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common shares from shares to be issued										287,802
Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of mezzanine equity into common shares						121,043				1,753,554
Shares recognised as obligation										121,043
Debt settled						$ 68,167				$ 2,145,929
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized				10,000,000					10,000,000		10,000,000
Preferred stock convertible conversion price				$ 0.001					$ 0.001		$ 0.001
Shares outstanding				201	201	201	6,305		201	201	201			201
Preferred Stock [Member] \| Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued				0		55	110		0	220	220
Net proceeds from new issue value				$ 0		$ 420,000	$ 925,000		$ 0	$ 1,732,532	$ 1,732,532
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares outstanding				26,952,280	26,728,441	23,023,933	9,514,440		26,952,280	23,023,933	26,241,967			21,645,068
Stock issued						287,802				608,123
Net proceeds from new issue value						$ 288				$ 608
Conversion of mezzanine equity into common shares				223,839		1,091,063		612,062	710,313	1,436,267
Conversion of common shares							$ 142,908	$ 228,727
Fair value of derivative liabilities				$ 102,769			$ 75,523	$ 119,359			$ 351,214
Number of stock issued during the period convertible, shares				223,839							3,650,361
Issuance of shares for settlement of accounts payable										1,000,413
Issuance of shares for settlement of accounts payable, value										$ 741,316
Issuance of shares for services										70,000
Shares to be issued with fair value										$ 70
Shares to be Issued [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares outstanding				581,599	581,599	194,998	344,276		581,599	194,998	581,599			321,757
Stock issued						(287,802)				(608,123)
Net proceeds from new issue value						$ (311,790)				$ (540,576)
Conversion of mezzanine equity into common shares
Converted issued shares							320,321
Issuance of shares for services						40,000				50,000
Shares to be issued with fair value						$ 20,000				$ 27,640

BIOTRICITY INC. 10-Q